TGFBR2 and hepatocellular carcinoma: Our AI-enhanced model improved accuracy (sensitivity of 0.7, specificity of 0.54) and revealed a reduction in TGFBR2 in HCC compared to cirrhotic tissue, highlighting its potential as a diagnostic tool.